| Gland Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543245 |
NSE Symbol : GLAND |
P/E(TTM) : 31.93 |
|
ISIN Demat : INE068V01023 |
Div & Yield% : 0.78 |
EPS(TTM) : 79.73 |
|
Book Value(₹) : 655.29 |
Market Cap(₹Cr) : 41,995.56 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,552.09 | 4,116.15 | 4,167.43 | 3,616.53 | 4,400.71 |
| Other Income | 303.90 | 215.08 | 166.67 | 240.46 | 223.94 |
| Stock Adjustments | 6.67 | -130.25 | -87.43 | 46.92 | -36.69 |
| Total Income | 4,862.66 | 4,200.98 | 4,246.67 | 3,903.91 | 4,587.96 |
| EXPENDITURE : | |||||
| Raw Materials | 1,801.82 | 1,600.35 | 1,732.88 | 1,732.34 | 2,072.53 |
| Power and Fuel Cost | 122.38 | 120.38 | 117.20 | 124.84 | 95.05 |
| Other Manufacturing Expenses | 209.14 | 188.89 | 186.92 | 153.84 | 137.19 |
| Selling and Administration Expenses | 197.33 | 155.54 | 175.97 | 189.65 | 177.43 |
| Miscellaneous Expenses | 60.53 | 39.10 | 48.31 | 100.99 | 32.61 |
| Employee Benefit Expenses | 528.82 | 439.02 | 409.95 | 399.70 | 338.57 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,942.62 | 1,657.70 | 1,575.44 | 1,202.55 | 1,734.58 |
| Interest | 18.07 | 22.84 | 7.84 | 7.41 | 5.24 |
| Gross Profit | 1,924.55 | 1,634.86 | 1,567.60 | 1,195.14 | 1,729.34 |
| Depreciation | 176.24 | 169.27 | 162.11 | 146.74 | 110.30 |
| Profit Before Tax | 1,748.31 | 1,465.59 | 1,405.49 | 1,048.40 | 1,619.04 |
| Current Tax | 452.59 | 366.71 | 337.49 | 275.38 | 392.88 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -3.83 | 9.12 | 24.68 | -2.80 | 14.01 |
| Reported Net Profit | 1,299.55 | 1,089.75 | 1,043.33 | 775.83 | 1,212.16 |
| Extraordinary Items | -15.68 | 1.64 | -0.39 | -39.55 | 3.22 |
| Adjusted Net Profit | 1,315.23 | 1,088.11 | 1,043.72 | 815.38 | 1,208.94 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 7,814.28 | 7,054.03 | 6,010.70 | 5,234.88 | 4,022.72 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 296.56 | 329.50 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 8,817.27 | 7,814.28 | 7,054.03 | 6,010.70 | 5,234.88 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 2,000.00 | 1,800.00 | 2,000.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 20.00 | 18.00 | 20.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 78.88 | 66.14 | 63.34 | 47.11 | 73.78 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 656.11 | 592.08 | 546.13 | 482.90 | 435.68 |
| Book Value(Adj)-Unit Curr | 656.11 | 592.08 | 546.13 | 482.90 | 435.68 |
